DMCCB Mini-Symposium: «Kinetics and Thermodynamics in Drug Discovery»

This year's annual mini-symposium organized by the Division of Medicinal Chemistry & Chemical Biology of the Swiss Chemical Society is dedicated to the topic of Kinetics and Thermodynamics in Drug Discovery.

This year's annual mini-symposium organized by the Division of Medicinal Chemistry & Chemical Biology of the Swiss Chemical Society is dedicated to the topic of Kinetics and Thermodynamics in Drug Discovery.

This free event is gathering five globally renowed experts in the field that will showcase the importance of this topic in drug discovery.

Confirmed Speakers:

• Gerhard Klebe, University of Marburg
  Correlation of structure, thermodynamics and molecular
  dynamics to better understand drug binding
• David Swinney, Institute for Rare and Neglected Diseases Drug Discovery
  Application of binding kinetics to drug discovery
• Göran Dahl, AstraZeneca 
  Pharmacokinetics and the drug-target residence time concept
• David Sykes, Novartis Institutes for Biomedical Research
  Exploring the relationship between β₂-adrenoceptor drug binding affinity/kinetic constants and physicochemical parameters
• Russel Petter, Celgene
  Design and optimization of targeted covalent inhibitors

Poster

Contact
Nikolaus Stiefl
Novartis Pharma AG
Forum1, Novartis Campus
4056 Basel
Email: